Why is Nectar Lifesci. falling/rising?

As of 07-Jul, Nectar Lifescience Ltd's stock price is currently at 23.16, reflecting an increase of 0.4, or 1.76%. The stock has shown a performance today that outperformed its sector by 1.84%. It is trading higher than its 5-day and 20-day moving averages, although it remains below its 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has gained 4.47%, contrasting with a slight decline of 0.20% in the Sensex. Despite a year-to-date decline of 40.62%, the company has reported a significant growth in net profit of 40% and has declared positive results for the last six consecutive quarters, which may contribute to the recent upward movement in its stock price.
In the broader market context, while Nectar Lifescience Ltd has outperformed its sector recently, it has underperformed the benchmark indices over longer periods, including a 26.27% decline over the past year compared to a 4.31% increase in the Sensex. The stock's weak long-term fundamental strength, indicated by a high Debt to EBITDA ratio and a low average Return on Equity, raises concerns about its sustainability. Additionally, the fact that 99.6% of promoter shares are pledged could exert downward pressure on the stock in a falling market. Overall, while recent positive financial results may have temporarily boosted the stock, the long-term outlook remains uncertain due to these underlying weaknesses.